Literature DB >> 19067114

Antiplasmodial and antitrypanosomal activity of plants from the Kingdom of Saudi Arabia.

Essam Abdel-Sattar1, Fathalla M Harraz, Soliman M A Al-Ansari, Sahar El-Mekkawy, Chikara Ichino, Hiroaki Kiyohara, Kazuhiko Otoguro, Satoshi Omura, Haruki Yamada.   

Abstract

The antiplasmodial and antitrypanosomal activity of the methanol extracts of 42 plants collected from the Kingdom of Saudi Arabia and some fractions obtained thereof were evaluated. The antiplasmodial activity was tested in vitro against chloroquine-resistant strain (K1) and sensitive strain (FCR3), and the antitrypanosomal activity was tested in vitro against Trypanosoma brucei brucei GUTat 3.1 strain. For host cells, the cytotoxicity of the active extracts was also evaluated against the MRC5 human cell line. Only extracts of three samples demonstrated good antiplasmodial activity (IC(50) < 12.5 and > 1.56 microg/ml, score 2), the methanol extracts of Lycium shawii, Heliotropium zeylanicum and the petroleum ether-soluble fraction of the methanol extract of Caralluma tuberculata, while extracts of the remaining 42 plants were inactive (IC(50) > 12.5 microg/ml, score 1). As for the antitrypanosomal activity, the methanol extract of Solanum schimperianum demonstrated the highest activity (IC(50) 0.061 microg/ml), followed by the petroleum ether-soluble fraction of the methanol extract of C. tuberculata (IC(50) 0.5 microg/ml). The chloroform-soluble fraction of the methanol extract of C. tuberculata was moderately active (IC(50) 3.5 microg/ml), with low cytotoxicity (IC(50) 62.6 microg/ml) and moderate selectivity index (SI 17.9). The methanolic extracts of 34 plants showed good activity with score 2 (IC(50) < 12.5 and > 1.56 microg/ml), while the extracts of seven plants were inactive (IC(50) > 12.5 microg/ml, score 1).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19067114     DOI: 10.1007/s11418-008-0305-5

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  23 in total

1.  The relation between funding by the National Institutes of Health and the burden of disease.

Authors:  C P Gross; G F Anderson; N R Powe
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

2.  Continuous growth of bloodstream forms of Trypanosoma brucei brucei in an axenic culture system containing a low concentration of serum.

Authors:  Y Yabu; T Koide; N Ohta; M Nose; Y Ogihara
Journal:  Southeast Asian J Trop Med Public Health       Date:  1998-09       Impact factor: 0.267

3.  The fall and rise of sleeping sickness.

Authors:  M P Barrett
Journal:  Lancet       Date:  1999-04-03       Impact factor: 79.321

4.  Strategic emphases for tropical diseases research: a TDR perspective.

Authors:  Jan H F Remme; Erik Blas; Lester Chitsulo; Philippe M P Desjeux; Howard D Engers; Thomas P Kanyok; Jane F Kayondo; Deborah W Kioy; Vasanthapuram Kumaraswami; Janis K Lazdins; Paul P Nunn; Ayoade Oduola; Robert G Ridley; Yeya T Toure; Fabio Zicker; Carlos M Morel
Journal:  Trends Microbiol       Date:  2002-10       Impact factor: 17.079

Review 5.  The treatment of human African trypanosomiasis.

Authors:  J Pépin; F Milord
Journal:  Adv Parasitol       Date:  1994       Impact factor: 3.870

6.  The global distribution of clinical episodes of Plasmodium falciparum malaria.

Authors:  Robert W Snow; Carlos A Guerra; Abdisalan M Noor; Hla Y Myint; Simon I Hay
Journal:  Nature       Date:  2005-03-10       Impact factor: 49.962

7.  Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity.

Authors:  M T Makler; J M Ries; J A Williams; J E Bancroft; R C Piper; B L Gibbins; D J Hinrichs
Journal:  Am J Trop Med Hyg       Date:  1993-06       Impact factor: 2.345

Review 8.  The global distribution and population at risk of malaria: past, present, and future.

Authors:  Simon I Hay; Carlos A Guerra; Andrew J Tatem; Abdisalan M Noor; Robert W Snow
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

9.  Trypanocidal activity of a new pterocarpan and other secondary metabolites of plants from Northeastern Brazil flora.

Authors:  Nashira Campos Vieira; Laila Salmen Espíndola; Jaime Martins Santana; Maria Leopoldina Veras; Otília Deusdênia Loiola Pessoa; Sávio Moita Pinheiro; Renata Mendonça de Araújo; Mary Anne Sousa Lima; Edilberto Rocha Silveira
Journal:  Bioorg Med Chem       Date:  2007-11-13       Impact factor: 3.641

10.  Kukoamine A and other hydrophobic acylpolyamines: potent and selective inhibitors of Crithidia fasciculata trypanothione reductase.

Authors:  J A Ponasik; C Strickland; C Faerman; S Savvides; P A Karplus; B Ganem
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

View more
  11 in total

1.  Larvicidal and pupicidal activities of ecbolin A and ecbolin B isolated from Ecbolium viride (Forssk.) Alston against Culex quinquefasciatus Say (Diptera: Culicidae).

Authors:  Kalaimaran Francina Cecilia; Ramalingam Ravindhran; Munusamy Rajiv Gandhi; Appadurai Daniel Reegan; Kedike Balakrishna; Savarimuthu Ignacimuthu
Journal:  Parasitol Res       Date:  2014-07-17       Impact factor: 2.289

2.  Cytotoxicity, mode of action and antibacterial activities of selected Saudi Arabian medicinal plants.

Authors:  Victor Kuete; Benjamin Wiench; Mansour S Alsaid; Muhammad A Alyahya; Aimé G Fankam; Abdelaaty A Shahat; Thomas Efferth
Journal:  BMC Complement Altern Med       Date:  2013-12-12       Impact factor: 3.659

3.  High-performance thin layer chromatography based assay and stress study of a rare steroidal alkaloid solanopubamine in six species of Solanum grown in Saudi Arabia.

Authors:  Nasir A Siddiqui; Mohammad K Parvez; Adnan J Al-Rehaily; Mohammed S Al Dosari; Perwez Alam; Faiyaz Shakeel; Hattan A Al Harbi
Journal:  Saudi Pharm J       Date:  2016-05-26       Impact factor: 4.330

4.  Bioefficacy of ecbolin A and ecbolin B isolated from Ecbolium viride (Forsk.) Alston on dengue vector Aedes aegypti L. (Diptera: Culicidae).

Authors:  Appadurai Daniel Reegan; Munusamy Rajiv Gandhi; Govindan Sivaraman; Kalaimaran Francina Cecilia; Ramalingam Ravindhran; Kedike Balakrishna; Michael Gabriel Paulraj; Savarimuthu Ignacimuthu
Journal:  Parasite Epidemiol Control       Date:  2016-04-06

5.  Interspecies Anticancer and Antimicrobial Activities of Genus Solanum and Estimation of Rutin by Validated UPLC-PDA Method.

Authors:  Mohamed Fahad Alajmi; Perwez Alam; Md Tabish Rehman; Fohad Mabood Husain; Azmat Ali Khan; Nasir Ali Siddiqui; Afzal Hussain; Mohd Abul Kalam; Mohammad Khalid Parvez
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-03       Impact factor: 2.629

6.  Study of the in vitro antiplasmodial, antileishmanial and antitrypanosomal activities of medicinal plants from Saudi Arabia.

Authors:  Nawal M Al-Musayeib; Ramzi A Mothana; Shaza Al-Massarani; An Matheeussen; Paul Cos; Louis Maes
Journal:  Molecules       Date:  2012-09-25       Impact factor: 4.411

7.  Evaluation of the in vitro antiplasmodial, antileishmanial, and antitrypanosomal activity of medicinal plants used in saudi and yemeni traditional medicine.

Authors:  Ramzi A Mothana; Nawal M Al-Musayeib; Mohamed F Al-Ajmi; Paul Cos; Louis Maes
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-21       Impact factor: 2.629

Review 8.  Plant-derived antimalarial agents: new leads and efficient phytomedicines. Part II. Non-alkaloidal natural products.

Authors:  Ronan Batista; Ademir de Jesus Silva; Alaíde Braga de Oliveira
Journal:  Molecules       Date:  2009-08-13       Impact factor: 4.411

9.  Effects of Caralluma russeliana stem extract on some physiological parameters in streptozotocin-induced diabetic male rats.

Authors:  Talal A Zari; Mesfer A Al-Thebaiti
Journal:  Diabetes Metab Syndr Obes       Date:  2018-10-12       Impact factor: 3.168

10.  Monolluma quadrangula Protects against Oxidative Stress and Modulates LDL Receptor and Fatty Acid Synthase Gene Expression in Hypercholesterolemic Rats.

Authors:  May N Bin-Jumah
Journal:  Oxid Med Cell Longev       Date:  2018-09-30       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.